Milena Pavlova, MD, neurologist, and medical director of the Sleep Testing Center at Brigham and Women’s Faulkner Hospital, highlights how even mild cases of sleep apnea can increase the number of seizures a patient with epilepsy experiences and harm organs.
Sleep conditions like sleep apnea, even mild cases, can escalate the number of seizures a patient with epilepsy experiences and injure organs due to oxygen deprivation, says Milena Pavlova, MD, neurologist, and medical director of the Sleep Testing Center at Brigham and Women’s Faulkner Hospital.
*This interview took place at the American Academy of Neurology 75th annual meeting in Boston
Transcript
What kinds of complications do you see in patients that have epilepsy and untreated sleep disorders?
It really depends on the sleep disorder. Probably the most glaring example is sleep apnea; patients not breathing well during sleep and waking up to breathe. Virtually anything that has a blood vessel gets worse from sleep apnea, because sleep apnea leads to lower oxygen level intermittently and that is harmful to the wall of the blood vessels. So, anything that has a blood vessel, whether it's the brain, heart, or any peripheral organ, it gets worse. When it comes to things that have to do with attention, cognition, and mood, this process of multiple times per hour waking up to breathe leads to poor sleep.
Poor sleep tends to worsen these disorders in multiple different ways. The easiest way to measure is frequency of seizures. It is now a recognized factor that can contribute to more frequent seizures; there has been research on this. One of the studies I will be citing is particularly interesting because they looked at seizures after the age of 50. And they divided the patients in 2 groups: One had patients who had well-controlled seizures, meaning they are taking their medications and their seizures have stopped happening, and the other group was patients who had either new onset of seizures or more frequent seizures after the age of 50. They found that those who have more frequent seizures have a much higher frequency of sleep apnea. It wasn't even necessarily severe sleep apnea—some of them had mild sleep apnea— but sufficient to worsen sleep and for the patient to have more frequent seizures.
I will be also talking about a couple of other studies that have been more recent that have examined whether treatment of sleep apnea can help improve the control of seizures. They have a very similar bottom line. People who are treated for sleep apnea and adherence to the treatment—meaning they are using the treatment that was tested with CPAP [continuous positive airway pressure] treatment, the first line therapy for sleep apnea—in both of these studies, the patients who were using more consistently the CPAP machine had a reduction in the number of their seizures, and in both studies, more than half of the patients became seizure free. So, a very, very striking example of the importance of treating sleep disorders in patients who have epilepsy.
STEER Data Open Door to SMA Gene Therapy for Wider Age Range of Children
March 19th 2025Delivery of onasemnogene abeparvovec into the intrathecal space was safe and effective for children with spinal muscular atrophy (SMA) aged 2 to 17 years, who had previously been shut out of receiving gene therapy.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
EMBARK Data Show Continued Improvements With DMD Gene Therapy
March 19th 2025Data from the EMBARK trial of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) show that benefits in functional outcomes, gene expression, and muscle imaging persist 2 years after receiving the gene therapy.
Read More
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More